Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-003172

President & CEO sold 100,000 shares at $10.38 ($1,038,000)

  • President & CEO acquired 100,000 shares (option exercise)
  • President & CEO gave 10,000 shares (gift)
  • President & CEO gave 10,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Stonehouse Jon P · President & CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-29 Gift : show line 1 in the form −10,000 1,008,739 D
2022-12-29 Gift : show line 2 in the form +5,000 10,000 I
2022-12-29 Gift : show line 3 in the form +5,000 10,000 I
2023-02-01 Exercise or conversion : show line 4 in the form +100,000 $5.45 $545,000 1,108,739 D
2023-02-01 Sale : show line 5 in the form −100,000 $10.38 $1,038,000 1,008,739 D
Open-market sales · 100,000 sh · avg $10.38 · $1,038,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-01 Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) −100,000 0 D
Loading xslF345X03/form4.xml…